Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES. uri icon

Overview

publication date

  • February 4, 2020

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Anticholesteremic Agents
  • Cholesterol, LDL

Identity

Scopus Document Identifier

  • 85078060913

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2019.11.030

PubMed ID

  • 32000957

Additional Document Info

volume

  • 75

issue

  • 4